2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol

C109H130N16O6 — CID 158878220

IUPAC2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol
SMILESCOc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CCC(O)C4)cc23)CC1.COc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CCC(OC)C4)cc23)CC1.Cc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CC[C@@H](O)C4)cc23)CC1.Cc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CC[C@H](O)C4)cc23)CC1
InChIInChI=1S/C28H34N4O2.C27H32N4O2.2C27H32N4O/c1-33-22-13-16-32(18-22)21-9-10-25-24(17-21)28(30-27(29-25)20-7-8-20)31-14-11-19(12-15-31)23-5-3-4-6-26(23)34-2;1-33-25-5-3-2-4-22(25)18-10-13-30(14-11-18)27-23-16-20(31-15-12-21(32)17-31)8-9-24(23)28-26(29-27)19-6-7-19;2*1-18-4-2-3-5-23(18)19-10-13-30(14-11-19)27-24-16-21(31-15-12-22(32)17-31)8-9-25(24)28-26(29-27)20-6-7-20/h3-6,9-10,17,19-20,22H,7-8,11-16,18H2,1-2H3;2-5,8-9,16,18-19,21,32H,6-7,10-15,17H2,1H3;2*2-5,8-9,16,19-20,22,32H,6-7,10-15,17H2,1H3/t;;2*22-/m..10/s1
InChIKeyJCSALNFZIXYQSX-RJHYWXQISA-N
MW1760.34 g/mol
LogP19.14
Rot. Bonds19

About 2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol

2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol (PubChem CID 158878220) has the molecular formula C109H130N16O6 and a molecular weight of 1760.34 g/mol. Its IUPAC name is 2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol.

Molecular Properties

Compound Name2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol
PubChem CID158878220
Molecular FormulaC109H130N16O6
Molecular Weight1760.34 g/mol
Exact Mass1759.04
IUPAC Name2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol
SMILESCOc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CCC(O)C4)cc23)CC1.COc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CCC(OC)C4)cc23)CC1.Cc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CC[C@@H](O)C4)cc23)CC1.Cc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CC[C@H](O)C4)cc23)CC1
InChIInChI=1S/C28H34N4O2.C27H32N4O2.2C27H32N4O/c1-33-22-13-16-32(18-22)21-9-10-25-24(17-21)28(30-27(29-25)20-7-8-20)31-14-11-19(12-15-31)23-5-3-4-6-26(23)34-2;1-33-25-5-3-2-4-22(25)18-10-13-30(14-11-18)27-23-16-20(31-15-12-21(32)17-31)8-9-24(23)28-26(29-27)19-6-7-19;2*1-18-4-2-3-5-23(18)19-10-13-30(14-11-19)27-24-16-21(31-15-12-22(32)17-31)8-9-25(24)28-26(29-27)20-6-7-20/h3-6,9-10,17,19-20,22H,7-8,11-16,18H2,1-2H3;2-5,8-9,16,18-19,21,32H,6-7,10-15,17H2,1H3;2*2-5,8-9,16,19-20,22,32H,6-7,10-15,17H2,1H3/t;;2*22-/m..10/s1
InChIKeyJCSALNFZIXYQSX-RJHYWXQISA-N
XLogP19.14
TPSA217.42 Ų
H-Bond Donors3
H-Bond Acceptors22
Rotatable Bonds19
Heavy Atoms131
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001760.34
LogP ≤ 519.14
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1022

Analyze 2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol?
The IUPAC name of 2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol (CID 158878220) is 2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol.
What is the SMILES notation for 2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol?
The canonical SMILES for 2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol is COc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CCC(O)C4)cc23)CC1.COc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CCC(OC)C4)cc23)CC1.Cc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CC[C@@H](O)C4)cc23)CC1.Cc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CC[C@H](O)C4)cc23)CC1.
What is the InChIKey of 2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol?
The InChIKey is JCSALNFZIXYQSX-RJHYWXQISA-N. The full InChI is InChI=1S/C28H34N4O2.C27H32N4O2.2C27H32N4O/c1-33-22-13-16-32(18-22)21-9-10-25-24(17-21)28(30-27(29-25)20-7-8-20)31-14-11-19(12-15-31)23-5-3-4-6-26(23)34-2;1-33-25-5-3-2-4-22(25)18-10-13-30(14-11-18)27-23-16-20(31-15-12-21(32)17-31)8-9-24(23)28-26(29-27)19-6-7-19;2*1-18-4-2-3-5-23(18)19-10-13-30(14-11-19)27-24-16-21(31-15-12-22(32)17-31)8-9-25(24)28-26(29-27)20-6-7-20/h3-6,9-10,17,19-20,22H,7-8,11-16,18H2,1-2H3;2-5,8-9,16,18-19,21,32H,6-7,10-15,17H2,1H3;2*2-5,8-9,16,19-20,22,32H,6-7,10-15,17H2,1H3/t;;2*22-/m..10/s1.
What are the key properties of 2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol?
2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol has a molecular weight of 1760.34 g/mol, XLogP of 19.14, 19 rotatable bonds, 3 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for 2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;1-[2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol is sourced from PubChem (CID 158878220), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).